# 3D Microscopy, Artificial Intelligence-based Quantification and Modeling for Non-Clinical Evaluation and Regulatory Support of Complex Drug Products

Canonical: https://abierto.us/opportunities/fda75f40124q00047

- Solicitation number: FDA-75F40124Q00047
- Notice type: Combined synopsis and solicitation
- Status: Closed. Deadline was May 23, 2024 at 2:30 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: AJ13 General Science & Technology R&D Svcs; General Science & Technology; Experimental Development
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: May 8, 2024
- Last posted: May 8, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/ada69bc175814a7ba01757e840c9a01b/view

## Description

This is a combined synopsis/solicitation for commercial services prepared in accordance with the Federal Acquisition Regulation (FAR) format in 15.204-1, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.

This solicitation authorized under FAR Part 12 “Acquisition of Commercial Products and Commercial Services” and 13.5 “Simplified Procedures for Certain Commercial Products and Commercial Services” is for the award of one (1) Indefinity Delivery Indefinite Quantity (IDIQ) contract. The solicitation number is FDA-75F40124Q00047. This solicitation is issued as a Request for Quote (RFQ). This is a Full and Open Competition.

The solicitation document and incorporated provisions and clauses in effect through the Federal Acquisition Circular 2024-04, effective 01 May 2024. FAR and HHSAR provisions and clauses referenced in this RFQ can be found on the following website: https://www.acquisition.gov/browse/index/far

## Publications

- May 8, 2024: Combined synopsis and solicitation, due May 23, 2024 at 2:30 PM EDT. Notice 9edbbdfcc1f64a518a6752833b15dea4. https://sam.gov/workspace/contract/opp/9edbbdfcc1f64a518a6752833b15dea4/view
- May 8, 2024: Combined synopsis and solicitation, due May 23, 2024 at 2:30 PM EDT. Notice ada69bc175814a7ba01757e840c9a01b. https://sam.gov/workspace/contract/opp/ada69bc175814a7ba01757e840c9a01b/view

## Points of contact

- Lillian Lamb, lillian.lamb@fda.hhs.gov, 3017961316

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fda75f40124q00047.